Our previous study demonstrated that CD36 plays a role in the proliferation and migration of oral squamous cell carcinoma (OSCC), suggesting its potential as a novel therapeutic target for oral cancer [9]. The gene discussed is CD36; the disease is lip and oral cavity carcinoma.